DLDRX
Price
$41.61
Change
+$0.39 (+0.95%)
Updated
Jun 3 closing price
Net Assets
1.06B
TRNEX
Price
$38.48
Change
+$0.27 (+0.71%)
Updated
Jun 3 closing price
Net Assets
2.3B
Interact to see
Advertisement

DLDRX vs TRNEX

Header iconDLDRX vs TRNEX Comparison
Open Charts DLDRX vs TRNEXBanner chart's image
BNY Mellon Natural Resources I
Price$41.61
Change+$0.39 (+0.95%)
VolumeN/A
Net Assets1.06B
T. Rowe Price New Era I
Price$38.48
Change+$0.27 (+0.71%)
VolumeN/A
Net Assets2.3B
DLDRX vs TRNEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLDRX vs. TRNEX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLDRX is a Hold and TRNEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.3B vs. DLDRX (1.06B). TRNEX pays higher dividends than DLDRX: TRNEX (2.27) vs DLDRX (1.51). DLDRX was incepted earlier than TRNEX: DLDRX (22 years) vs TRNEX (9 years). DLDRX (0.75) is less costly to investors than TRNEX (0.57). DLDRX is a more actively managed with annual turnover of: 103.94 vs. TRNEX (24.30). DLDRX has a lower initial minimum investment than TRNEX: DLDRX (1000) vs TRNEX (500000). TRNEX annual gain was more profitable for investors over the last year : -3.63 vs. DLDRX (-19.64). DLDRX return over 5 years is better than : 70.29 vs. TRNEX (53.70).
DLDRXTRNEXDLDRX / TRNEX
Total Expense Ratio0.890.57156%
Annual Report Gross Expense Ratio0.750.57132%
Fund Existence22 years9 years-
Gain YTD-5.7832.964-195%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.06B2.3B46%
Annual Yield % from dividends1.512.2767%
Returns for 1 year-19.64-3.63542%
Returns for 3 years-32.05-5.37596%
Returns for 5 years70.2953.70131%
Returns for 10 years44.58N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QASGX25.250.39
+1.57%
Federated Hermes MDT Small Cap Growth A
JFNSX61.870.21
+0.34%
Janus Henderson Global Life Sciences S
TMCAX11.53N/A
N/A
RBC SMID Cap Growth A
JEMZX9.51N/A
N/A
JHancock Emerging Markets Equity C
EEMHX8.60N/A
N/A
MFS Emerging Markets Equity Research R6